RT Journal Article
SR Electronic
T1 Confirmed forecasts for the expansion of the COVID-19 epidemic in the largest Brazilian City
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.08.21251290
DO 10.1101/2021.02.08.21251290
A1 Celaschi, Sergio
YR 2021
UL http://medrxiv.org/content/early/2021/05/07/2021.02.08.21251290.abstract
AB Objective A SEIR compartmental model was previously selected to estimate future outcomes to the dynamics of the Covid-19 epidemic breakout in Brazil.Method Compartments for individuals vaccinated, and prevalent SARS-Cov-2 variants were not included. A time-dependent incidence weight on the reproductive basic number accounted for Non Pharmaceutical Interventions (NPI). A first series of published data from March 1st to May 8, 2020 was used to adjust all model parameters aiming to forecast one year of evolutionary outbreak. The cohort study was set as a city population-based analysis.Analysis The population-based sample, 25,366 during the study period, was the number of confirmed cases on exposed individuals. The analysis was applied to predict the consequences of holding for posterior NPI releases, and indicates the appearance of a second wave starting last quarter of 2020.Findings By March 1st2021, the number of confirmed cases was predicted to reach 0.47Million (0.24-0.78), and fatalities would account for 21 thousand (12-33), 5 to 95% CRI. A second series of data published from May 9, 2020 to March 1st, 2021 confirms the forecasts previously reported for the evolution of infected people and fatalities.Novelty By March 1st 2021, the number of confirmed cases reached 527,710 (12% bellow predicted average of accumulated cases), and fatalities accounted for 18,769 (10% above the accumulated average of estimated fatalities). After March 1st, new peaks on reported numbers of daily new infected and new fatalities appeared as a combined result to the appearance of the prevalent SARS-CoV-2 P1 variant, and the increased number of vaccinated individuals.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis cohort study uses only official public dataClinical Protocols http://http//:www.theijes.com/papers/vol9-issue7/Ser-2/E0907023342.pdf Funding StatementFinancial grant by FUNTTEL - Financial grant # 01.16.0053.01 FINEP/MCTI, Brazilian Ministry of Science, Communications, and Innovation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is providedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll available data in the manuscript was previously published by the Brazilian government. http://www.saopaulo.sp.gov.br/wp-content/uploads/2021/01/20210131_dados_covid_municipios_sp.csv